Toro Company (The) Common Stock vs DENTSPLY SIRONA Inc — how do they compare? Toro Company (The) Common Stock trades at $98.27 (market cap $9.27B), while DENTSPLY SIRONA Inc trades at $8.54 (market cap $1.70B). The key difference: Toro Company (The) Common Stock is far larger — about 5.5× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals — on Pluang, investors hold Toro Company (The) Common Stock for 0 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| TTC | XRAY | |
|---|---|---|
Market Cap | $9.27B | $1.70B |
Volume | 688,325 | 3,939,845 |
Sector | Industrials | Health |
52-Week High | $101.76 | $14.68 |
52-Week Low | $67.99 | $8.44 |
Typical Hold Time | 0 Days | 72 Days |
Enterprise Value | $10.17B | $3.77B |
Dividend Yield | 1.59% | 5.04% |
Signals from Pluang's Aura AI — not financial advice
Toro Company (TTC) trades at $97.88, up 1.27% with strong technical momentum above its 50-day moving average. The company demonstrates solid fundamentals with consistent earnings beats, including Q2 2026 EPS of $1.33 beating expectations of $1.31, and raised full-year guidance. Revenue growth of 8.4% in Q3 2026 to $1.23 billion reflects robust demand across professional and residential segments, supported by infrastructure and automation initiatives under new CEO leadership.
Toro presents a balanced investment case with 36% analyst buy ratings and $117.50 price target suggesting 20% upside. However, execution risks from inflation, tariffs, and competitive pressures warrant caution. The stock's premium valuation (P/E 26.17) requires sustained earnings growth, making Q3 2026 results critical for validating current momentum.
XRAY trades at $8.44, down 1.06% on the day and near its 52-week low, reflecting persistent bearish technical signals. The company reported a net loss of $598 million in 2025, with negative profit margins and declining revenue, though Q2 2026 earnings beat expectations. Debt-to-asset ratio has risen to 42.88% in 2025, indicating increased financial leverage amid ongoing restructuring efforts.
The outlook remains challenging with weak profitability and high debt, but analyst consensus suggests potential upside to a $13.00 price target. Key risks include margin pressure, competitive threats, and execution of the turnaround plan. Investment appeal hinges on successful operational improvements and sustained earnings recovery.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
The Toro Company designs, manufactures, and markets equipment for turf maintenance, snow and ice management, landscaping, construction, and irrigation. Its products serve golf courses, sports fields, and residential and commercial properties in more than 125 countries.
Read more on TTC →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →